We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+5.65%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.01B
AUM Growth
+$205M
(+25%)
Cap. Flow
+$234M
Cap. Flow
% of AUM
23.15%
Top 10 Holdings %
Top 10 Hldgs %
4.25%
Holding
2,085
New
689
Increased
399
Reduced
339
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
National Vision
EYE
|
+$5.45M |
| 2 |
Altimmune
ALT
|
+$4.45M |
| 3 |
FRC
First Republic Bank
FRC
|
+$4.06M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.99M |
| 5 |
Hilton Worldwide
HLT
|
+$3.96M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$7.74M |
| 2 |
Dropbox
DBX
|
+$3.02M |
| 3 |
Progressive
PGR
|
+$2.77M |
| 4 |
Southwest Airlines
LUV
|
+$2.69M |
| 5 |
Transocean
RIG
|
+$2.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 14.87% |
| 3 | Healthcare | 14.13% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 11.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Adeia
ADEA
$3.11B
| $471K | 0.05% |
+53,131
| New | +$531K |
|
|
RNAM
752
DELISTED
Avidity Biosciences
RNAM
| $471K | 0.05% |
30,662
-20,977
| -41% | -$462K |
|
753
Royalty Pharma
RPRX
$25.3B
| $471K | 0.05% |
+13,069
| New | +$485K |
|
|
PARA
754
DELISTED
Paramount Global Class B
PARA
| $470K | 0.05% |
21,087
-23,277
| -52% | -$499K |
|
755
Allison Transmission
ALSN
$9.82B
| $468K | 0.05% |
10,334
-13,834
| -57% | -$622K |
|
756
AtriCure
ATRC
$2.11B
| $468K | 0.05% |
+11,279
| New | +$468K |
|
|
DAO
757
Youdao
DAO
$2.19B
| $468K | 0.05% |
55,064
-31,965
| -37% | -$253K |
|
758
Granite Construction
GVA
$5.62B
| $468K | 0.05% |
11,382
-23,405
| -67% | -$953K |
|
759
Universal Logistics Holdings
ULH
$529M
| $468K | 0.05% |
16,069
+2,317
| +17% | +$75.2K |
|
|
AZUL
760
DELISTED
Azul
AZUL
| $467K | 0.05% |
+65,308
| New | +$409K |
|
761
PagSeguro Digital
PAGS
$2.55B
| $467K | 0.05% |
54,536
+19,990
| +58% | +$179K |
|
|
ESTE
762
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $466K | 0.05% |
+35,856
| New | +$481K |
|
763
ScottsMiracle-Gro
SMG
$3.66B
| $465K | 0.05% |
+6,673
| New | +$480K |
|
764
SmartRent
SMRT
$272M
| $464K | 0.05% |
+181,945
| New | +$488K |
|
765
Yelp
YELP
$1.41B
| $464K | 0.05% |
15,100
-6,215
| -29% | -$187K |
|
766
BridgeBio Pharma
BBIO
$16.5B
| $463K | 0.05% |
27,908
-9,593
| -26% | -$112K |
|
767
Cardiff Oncology
CRDF
$77.2M
| $463K | 0.05% |
280,679
-71,507
| -20% | -$123K |
|
768
iShares Latin America 40 ETF
ILF
$3.83B
| $463K | 0.05% |
+19,390
| New | +$466K |
|
769
Enterprise Products Partners
EPD
$81.7B
| $462K | 0.05% |
17,820
+3,409
| +24% | +$87.6K |
|
770
Cartesian Therapeutics
RNAC
$268M
| $462K | 0.05% |
11,091
-1,312
| -11% | -$61.7K |
|
771
Carter Bankshares
CARE
$731M
| $460K | 0.05% |
32,852
+19,831
| +152% | +$320K |
|
772
Eagle Bancorp
EGBN
$845M
| $459K | 0.05% |
+13,713
| New | +$586K |
|
773
Similarweb
SMWB
$658M
| $459K | 0.05% |
+67,879
| New | +$435K |
|
774
Fidelity MSCI Real Estate Index ETF
FREL
$1.49B
| $457K | 0.05% |
+18,340
| New | +$473K |
|
775
Sysco
SYY
$40.3B
| $457K | 0.05% |
5,923
+2,535
| +75% | +$195K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q1 2023 Portfolio in Review
As of Q1 2023, GSA Capital Partners held 2,085 positions worth $1.01B, up 25% from $806M the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.
GSA Capital Partners deployed $234M of net new capital in Q1 2023, opening 689 new positions and adding to 399 existing holdings. Its largest new stake was National Vision: 167,499 shares worth $3.16M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Transocean, an estimated $2.59M trimmed.
- GSA Capital Partners's largest Q1 2023 buy was National Vision: 167,499 shares worth $3.16M.
- GSA Capital Partners added most to Altimmune in Q1 2023, an estimated $4.45M increase.
- GSA Capital Partners's biggest Q1 2023 reduction was Transocean, cutting an estimated $2.59M.
- GSA Capital Partners fully exited PG&E in Q1 2023, selling an estimated $7.74M.
- GSA Capital Partners's ten largest holdings make up 4.2% of its $1.01B portfolio in Q1 2023.
- GSA Capital Partners opened 689 new positions and closed 654 in Q1 2023.
- GSA Capital Partners's portfolio value rose 25% quarter-over-quarter to $1.01B.
Based on GSA Capital Partners's 13F filing for Q1 2023, filed 12 May 2023.